Cargando…

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers

A better understanding of multimolecular interactions involved in tumor dissemination is required to identify new effective therapies for advanced prostate cancer (PCa). Several groups investigated protein-glycan interactions as critical factors for crosstalk between prostate tumors and their microe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laderach, Diego J., Gentilini, Lucas, Jaworski, Felipe M., Compagno, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800608/ https://www.ncbi.nlm.nih.gov/pubmed/24205440 http://dx.doi.org/10.1155/2013/519436

Ejemplares similares

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013)

Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome
por: Tiraboschi, Carolina, et al.
Publicado: (2020)

Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
por: Gentilini, Lucas Daniel, et al.
Publicado: (2017)

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
por: Corapi, Enrique, et al.
Publicado: (2018)

Inhibition of galectins in cancer: Biological challenges for their clinical application
por: Laderach, Diego José, et al.
Publicado: (2023)

Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure
por: Laderach, Diego José, et al.
Publicado: (2021)

Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
por: Compagno, Daniel, et al.
Publicado: (2020)

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2014)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Publicado: (2015)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2020)

Galectins—Potential Therapeutic Targets for Neurodegenerative Disorders
por: Chaudhary, Sapana, et al.
Publicado: (2022)

Galectin signatuares contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
por: Grosset, Andrée-Anne, et al.
Publicado: (2016)

Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer
por: Sharma, Satish, et al.
Publicado: (2022)

The significance of galectin-3 as a new basal cell marker in prostate cancer
por: Wang, Y, et al.
Publicado: (2013)

Galectins as Molecular Targets for Therapeutic Intervention
por: Dings, Ruud P. M., et al.
Publicado: (2018)

Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
por: Videla-Richardson, Guillermo A., et al.
Publicado: (2021)

Prognostic value of galectin-3, a novel marker of fibrosis
por: Lok, Dirk J., et al.
Publicado: (2010)

Galectin-3 as an important prognostic marker for COVID-19 severity
por: Gajovic, Nevena, et al.
Publicado: (2023)

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease
por: Kar, Souvik, et al.
Publicado: (2023)

Prognostic marker and target in prostate cancer
por: Lavorgna, Giovanni, et al.
Publicado: (2015)

Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target
por: Velickovic, Milica, et al.
Publicado: (2021)

431 Galectin-3 as a Biomarker and Potential Therapeutic Target in Biliary Atresia
por: Yoeli, Dor, et al.
Publicado: (2022)

Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases
por: Nangia-Makker, Pratima, et al.
Publicado: (2022)

Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology
por: Hara, Akira, et al.
Publicado: (2020)

Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
por: Liu, Dan, et al.
Publicado: (2023)

The role of galectins-1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2022)

Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
por: Soccio, Raymond E
Publicado: (2021)

The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
por: Sygitowicz, Grażyna, et al.
Publicado: (2021)

SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
por: Jiang, Ming, et al.
Publicado: (2020)

The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?
por: Zaborska, Beata, et al.
Publicado: (2023)

Serum Galectin-3 as a Potential Marker for Gastric Cancer
por: Cheng, Daye, et al.
Publicado: (2015)

Galectin-1 as a potential cancer target
por: Rabinovich, G A
Publicado: (2005)

Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target
por: Boutin, Louis, et al.
Publicado: (2022)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017)

Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer
por: Barquilha, Caroline N., et al.
Publicado: (2020)

Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
por: Capone, Emily, et al.
Publicado: (2021)

Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis
por: Kram, Michael
Publicado: (2023)

DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
por: Song, L. J., et al.
Publicado: (2016)

Vitamin D as a Potential Therapeutic Target and Prognostic Marker for Colorectal Cancer
por: Bintintan, Vasile V.
Publicado: (2018)

Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
por: Grönberg, Malin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0jda0vmr3kmp03etisscvjmr5f